| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.4B | $11.8B | $12.0B | $12.9B | $11.4B | $3.0B | $2.8B | $2.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | $0.5B | $0.4B | $0.4B |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $0.6B | $0.6B | $0.6B | $0.6B | $0.6B | $0.6B | $0.6B | $0.6B |
| Operating Income | $1.6B | $1.4B | $1.3B | $1.3B | $1.4B | $0.3B | $0.2B | $1.1B |
| Net Income | $0.7B | $0.4B | $0.5B | $0.7B | $-0.6B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $6.41 | $3.56 | $3.77 | $6.01 | $-4.30 | $1.13 | $0.65 | $0.40 |
| EPS (Diluted) | $6.38 | $3.55 | $3.76 | $5.99 | $-4.30 | $1.12 | $0.64 | $0.40 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.3B | $13.8B | $15.0B | $14.3B | $13.9B | $16.7B | $15.5B | $15.3B |
| Current Assets | $4.4B | $4.2B | $4.8B | $4.7B | $4.5B | $4.9B | $4.0B | $4.1B |
| Cash & Equivalents | $0.8B | $0.9B | $1.3B | $0.6B | $0.5B | $1.2B | $0.6B | $0.6B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $4.3B | $3.5B | $4.2B | $3.9B | $4.1B | $4.3B | $3.9B | $3.9B |
| Stockholders' Equity | $3.0B | $2.8B | $2.4B | $1.8B | $1.9B | $2.2B | $1.7B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $1.2B | $1.5B | $0.8B | $0.9B | $1.3B | $1.2B | $0.6B |
| Investing Cash Flow | $-0.3B | $-0.0B | $-0.8B | $-0.6B | $1.5B | $-0.5B | $-0.4B | $-3.8B |
| Capital Expenditures | $0.4B | $0.4B | $0.8B | $0.8B | $0.8B | $0.6B | $0.4B | $0.5B |
| Financing Cash Flow | $-1.4B | $-1.5B | $0.1B | $-0.0B | $-2.9B | $-0.2B | $-0.8B | $3.5B |